Opioid Stocks List

Recent Signals

Date Stock Signal Type
2021-04-13 AMPH Jack-in-the-Box Bearish Bearish Swing Setup
2021-04-13 AMPH Bollinger Band Squeeze Range Contraction
2021-04-13 AQST Doji - Bullish? Reversal
2021-04-13 AQST NR7 Range Contraction
2021-04-13 AQST Narrow Range Bar Range Contraction
2021-04-13 ASRT Narrow Range Bar Range Contraction
2021-04-13 ATXI Fell Below 50 DMA Bearish
2021-04-13 ATXI Fell Below 20 DMA Bearish
2021-04-13 ATXI Calm After Storm Range Contraction
2021-04-13 ATXI MACD Bearish Signal Line Cross Bearish
2021-04-13 ATXI Volume Surge Other
2021-04-13 BDSI Bollinger Band Squeeze Range Contraction
2021-04-13 BWAY NR7 Range Contraction
2021-04-13 BWAY MACD Bearish Signal Line Cross Bearish
2021-04-13 BWAY Narrow Range Bar Range Contraction
2021-04-13 BWAY 20 DMA Support Bullish
2021-04-13 BXRX Lower Bollinger Band Walk Weakness
2021-04-13 BXRX New Downtrend Bearish
2021-04-13 COLL Narrow Range Bar Range Contraction
2021-04-13 COLL NR7 Range Contraction
2021-04-13 DRRX Doji - Bullish? Reversal
2021-04-13 JAN Narrow Range Bar Range Contraction
2021-04-13 JAN 180 Bullish Setup Bullish Swing Setup
2021-04-13 JAN 20 DMA Support Bullish
2021-04-13 JAN 50 DMA Support Bullish
2021-04-13 JAN NR7 Range Contraction
2021-04-13 LQDA Doji - Bullish? Reversal
2021-04-13 MJ Stochastic Reached Oversold Weakness
2021-04-13 NKTR Stochastic Buy Signal Bullish
2021-04-13 OPNT Pocket Pivot Bullish Swing Setup
2021-04-13 OPNT Crossed Above 20 DMA Bullish
2021-04-13 PRFX Stochastic Buy Signal Bullish
2021-04-13 PRFX New 52 Week Low Weakness
2021-04-13 PRFX New Downtrend Bearish
2021-04-13 PRFX New 52 Week Closing Low Bearish
2021-04-13 PRFX Expansion Breakdown Bearish Swing Setup
2021-04-13 REPH Fell Below 200 DMA Bearish
2021-04-13 SRGA New Downtrend Bearish
2021-04-13 SRGA Stochastic Reached Oversold Weakness
2021-04-13 TEVA Bollinger Band Squeeze Range Contraction
2021-04-13 TRVI Lower Bollinger Band Walk Weakness
2021-04-13 TRVN Spinning Top Other
2021-04-13 TTNP New 52 Week Closing Low Bearish
2021-04-13 TTNP New 52 Week Low Weakness
2021-04-13 TTNP Lower Bollinger Band Walk Weakness
2021-04-13 TTNP Stochastic Reached Oversold Weakness
2021-04-13 ZGNX MACD Bearish Signal Line Cross Bearish

Recent News for Opioid Stocks

Date Stock Title
Apr 13 AMPH Amphastar Pharmaceuticals (AMPH) Presents At 20th Annual Needham Virtual Healthcare Conference
Apr 13 ATXI Why Fortress Biotech Stock Is Sinking Today
Apr 13 ATXI Mid-Afternoon Market Update: Dow Falls 75 Points; vTv Therapeutics Shares Spike Higher
Apr 13 ATXI Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Avenue Therapeutics, Inc. (ATXI) Investigation
Apr 13 ATXI JAZZ's Xywav sNDA for Hypersomnia Gets FDA Priority Review
Apr 13 ATXI Avenue Therapeutics shares slide after IV tramadol NDA update
Apr 13 LQDA Liquidia launches $21.7M private placement.
Apr 13 ATXI 25 Stocks Moving in Tuesday's Pre-Market Session
Apr 13 LQDA Liquidia Corporation Announces $21.7 Million Private Placement
Apr 13 ATXI Avenue Therapeutics Announces that the FDA is Still Reviewing Its NDA Resubmission for IV Tramadol
Apr 13 TEVA Would Shareholders Who Purchased Teva Pharmaceutical Industries' (NYSE:TEVA) Stock Five Years Be Happy With The Share price Today?
Apr 12 AQST Rosen, Leading Trial Attorneys, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AQST
Apr 12 AQST FINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Apr 12 MJ POTX is the worst performing ETF at the midpoint of trading
Apr 12 BXRX Are Options Traders Betting on a Big Move in Baudax (BXRX) Stock?
Apr 12 ATXI BABA, MARA, NUAN and CVAC among notable premarket gainers
Apr 12 ATXI 28 Stocks Moving in Monday's Pre-Market Session
Apr 12 ATXI Is Avenue Therapeutics (NASDAQ:ATXI) In A Good Position To Deliver On Growth Plans?
Apr 10 AQST ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action – AQST
Apr 10 ATXI The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight

Opioids are substances that act on opioid receptors to produce morphine-like effects. Medically they are primarily used for pain relief, including anesthesia. Other medical uses include suppression of diarrhea, replacement therapy for opioid use disorder, reversing opioid overdose, suppressing cough, suppressing opioid induced constipation, as well as for executions in the United States. Extremely potent opioids such as carfentanil are only approved for veterinary use. Opioids are also frequently used non-medically for their euphoric effects or to prevent withdrawal.

Side effects of opioids may include itchiness, sedation, nausea, respiratory depression, constipation, and euphoria. Tolerance and dependence will develop with continuous use, requiring increasing doses and leading to a withdrawal syndrome upon abrupt discontinuation. The euphoria attracts recreational use and frequent, escalating recreational use of opioids typically results in addiction. An overdose or concurrent use with other depressant drugs commonly results in death from respiratory depression.Opioids act by binding to opioid receptors, which are found principally in the central and peripheral nervous system and the gastrointestinal tract. These receptors mediate both the psychoactive and the somatic effects of opioids. Opioid drugs include partial agonists, like the anti-diarrhea drug loperamide and antagonists like naloxegol for opioid-induced constipation, which do not cross the blood-brain barrier, but can displace other opioids from binding to those receptors.
Because opioids are addictive and may result in fatal overdose, most are controlled substances. In 2013, between 28 and 38 million people used opioids illicitly (0.6% to 0.8% of the global population between the ages of 15 and 65). In 2011, an estimated 4 million people in the United States used opioids recreationally or were dependent on them. As of 2015, increased rates of recreational use and addiction are attributed to over-prescription of opioid medications and inexpensive illicit heroin. Conversely, fears about over-prescribing, exaggerated side effects and addiction from opioids are similarly blamed for under-treatment of pain.

More about Opioid
Browse All Tags